| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050578223 |
| P356 | DOI | 10.1186/1741-7015-11-231 |
| P932 | PMC publication ID | 4231603 |
| P698 | PubMed publication ID | 24168211 |
| P5875 | ResearchGate publication ID | 258145705 |
| P50 | author | Andrew D. Kerkhoff | Q89596566 |
| Monica Vogt | Q116782384 | ||
| Stephen Lawn | Q28151824 | ||
| Robin Wood | Q60590121 | ||
| P2860 | cites work | Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease | Q81360033 |
| Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design | Q81473089 | ||
| Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings | Q83397592 | ||
| Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy | Q84728067 | ||
| The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study | Q28474623 | ||
| Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study | Q28479309 | ||
| The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce | Q28727351 | ||
| Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies | Q28743478 | ||
| Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa | Q30653441 | ||
| Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting | Q33625883 | ||
| Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments | Q33754177 | ||
| Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community | Q34222186 | ||
| Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review | Q34247819 | ||
| Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey | Q34384993 | ||
| Causes of death on antiretroviral therapy: a post-mortem study from South Africa | Q34456362 | ||
| Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa | Q34589601 | ||
| High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening | Q35124356 | ||
| Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis | Q35336481 | ||
| Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study | Q35859708 | ||
| High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay | Q36062867 | ||
| Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. | Q36825344 | ||
| Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test | Q36833723 | ||
| Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa | Q37265947 | ||
| Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis | Q37275878 | ||
| Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa | Q37285167 | ||
| Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control | Q39163402 | ||
| The mortality and pathology of HIV infection in a west African city. | Q39192788 | ||
| Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya | Q39540804 | ||
| An algorithm for tuberculosis screening and diagnosis in people with HIV. | Q40365481 | ||
| Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre, Malawi. | Q40566867 | ||
| Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic | Q46214222 | ||
| Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact | Q46456488 | ||
| Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individuals | Q46726042 | ||
| Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study | Q48029307 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tuberculosis | Q12204 |
| sputum | Q259346 | ||
| P304 | page(s) | 231 | |
| P577 | publication date | 2013-10-29 | |
| P1433 | published in | BMC Medicine | Q4835947 |
| P1476 | title | HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays | |
| P478 | volume | 11 |
| Q38346777 | Clinical Aspects of Adult Tuberculosis |
| Q35972660 | Comparative Yield of Different Diagnostic Tests for Tuberculosis among People Living with HIV in Western Kenya |
| Q54957532 | Correlation of Xpert MTB/RIF with measures to assess Mycobacterium tuberculosis bacillary burden in high HIV burden areas of Southern Africa. |
| Q26765388 | Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications |
| Q42221349 | Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres |
| Q34098274 | Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults |
| Q35795483 | Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana–findings from the DETECT HIV-TB study |
| Q36315432 | Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort |
| Q36160928 | Economic challenges associated with tuberculosis diagnostic development |
| Q38265418 | Evaluation of the Cepheid Xpert MTB/RIF assay |
| Q24185754 | Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults |
| Q91629917 | Molecular Diagnostics for AIDS Lymphoma Diagnosis in South Africa and the Potential for Other Low- and Middle-Income Countries |
| Q90365200 | Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data |
| Q36218341 | Performance of Clinical Screening Algorithms for Tuberculosis Intensified Case Finding among People Living with HIV in Western Kenya |
| Q37694942 | Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays |
| Q33975232 | Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis |
| Q35961735 | Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium |
| Q40065599 | The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012-2014. |
| Q58736880 | The Early Recognition and Management of Sepsis in Sub-Saharan African Adults: A Systematic Review and Meta-Analysis |
| Q40095857 | The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study |
| Q35544835 | The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study |
| Q35961812 | The role of rapid diagnostic tests in managing adults with pneumonia in low-resource settings |
| Q30383131 | Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar |
| Q55512467 | Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes. |
| Q57787695 | Urinary LAM grade, culture positivity, and mortality among HIV-infected South African out-patients |
| Q64892191 | Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. |
| Q57688853 | Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance |
Search more.